Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California.

The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.

[3] In 2024 the US FDA gave accelerated approval to Lifileucel, the company's tumor-infiltrating lymphocyte drug for the treatment of unresectable or metastatic melanoma.

[4] This United States corporation or company article is a stub.

You can help Wikipedia by expanding it.This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.